… This study shows that the proportion of young women diagnosed as having genital warts
has continued to decline since the quadrivalent human papillomavirus vaccination programme …

… of the national HPV vaccination program on private in-patient treatments for genital warts. …
the impact of the HPV vaccine program on in-patient treatment of genital warts in Australia. We …

… National incidence of genital warts in Denmark has declined since the implementation of
a national human papillomavirus vaccination program with a quadrivalent vaccine, with …

… Age-specific rates of admissions involving genital warts during July 1999–… of National HPV
Vaccination Program among females. … of National HPV Vaccination Program among females. …

… Proportion of patients aged <21 years, diagnosed as having genital warts by risk group …
Our primary objective was to determine the population effect of the HPV vaccination programme …

… evidence that the quadrivalent HPV vaccination program has led to a decreased management
rate of genital warts in general practice among those women of vaccine-eligible age. This …

… genital warts hospitalisations according to socioeconomic and geographic factors, both
in females vaccinated at school and in the community. The indirect impact on genital warts …

… The pilot showed feasibility and acceptability (45.5% recorded first dose uptake) and a
national HPV vaccination programme for MSM (up to and including 45 years of age) is being …

… The quadrivalent human papillomavirus (HPV) vaccine currently being delivered to … National
HPV Vaccination Program promises to substantially reduce the incidence of genital warts. …

… To assess the effectiveness of the HPV vaccines in preventing genital warts (GW) in women
aged … by number of doses: Systematic review of data from national immunization programs …